en
Feedback
Medicine and surgery🫀🧠

Medicine and surgery🫀🧠

Open in Telegram

Find me on twitter @ANHMM1418

Show more

📈 Analytical overview of Telegram channel Medicine and surgery🫀🧠

Channel Medicine and surgery🫀🧠 (@medachool_summaries) in the English language segment is an active participant. Currently, the community unites 22 732 subscribers, ranking 972 in the Medicine category and 3 089 in the Saudi Arabia region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 22 732 subscribers.

According to the latest data from 08 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -81 over the last 30 days and by -3 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 8.61%. Within the first 24 hours after publication, content typically collects 2.04% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 1 957 views. Within the first day, a publication typically gains 463 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
  • Thematic interests: Content is focused on key topics such as المتجر, كورس, bloodstream, crbsi, effusion.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
Find me on twitter @ANHMM1418

Thanks to the high frequency of updates (latest data received on 09 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

22 732
Subscribers
-324 hours
-367 days
-8130 days
Posts Archive
Repost from N/a
Sickle cell disease
Sickle cell disease

Repost from N/a
G6PD deficiency
G6PD deficiency

When to use ESA/EPO in CKD? —> if hgb <9-10 What is the target hgb? —> <11.5 (not higher !!, worse outcome) What
When to use ESA/EPO in CKD? —> if hgb <9-10 What is the target hgb? —> <11.5 (not higher !!, worse outcome) What is the pre-requisite? Iron —> Transferrin sat of 30% and ferritin 500 What is the contraindication? —> Stroke —> Active malignancy What is the route? pre-Hemodialysis stage —> oral then IV if failed HD patient —> IV right away What are the side effects? 1—> HTN 2—> Iron deficiency (consumed) 3—> Thrombosis (Heavy molecule) 4—>Bone pain (it worse on bone marrow !!) 5—> Pure red cell aplasia (due to antibodies against EPO) What are the causes of EPO resistance? 1—> factory problem (MDS, pure red cell plasia, myelofibrosis, Sickle cell) 2—> Product not available (B12, folate, iron deficiency) 3—> Ongoing problem (ongoing inflammation or malignancy) 4—> Machine problem (inadequate dialysis) 5—> miscellaneous (HIV, dialysis line infection, hyperparathyroidism)

Iron deficiency anemia
Iron deficiency anemia

Repost from N/a
manifestation of hypercalcemia
manifestation of hypercalcemia

Lymphadenopathy
Lymphadenopathy

Simplified version of solid pulmonary nodule 🔺When to repeat testing based on CT finding of SOLID pulmonary nodule 🔻
Simplified version of solid pulmonary nodule 🔺When to repeat testing based on CT finding of SOLID pulmonary nodule 🔻

Repost from N/a
🔰 Incidental pulmonary nodules: multiple solid nodules: ▫️ Low risk patients: 1️⃣ &lt; 6 mm 👉🏽 No follow up 2️⃣ 6-8 or mor
🔰 Incidental pulmonary nodules: multiple solid nodules: ▫️ Low risk patients: 1️⃣ < 6 mm 👉🏽 No follow up 2️⃣ 6-8 or more 👉🏽 Follow up in 3-6 months 👉🏽 then consider CT at 18-24 months ▫️High risk patients: 1️⃣ < 6 mm 👉🏽 Optional CT at 12 months 2️⃣ 6-8 or more 👉🏽 Follow up in 3-6 months 👉🏽 then consider CT at 18-24 months

🔺 Minimum duration of Dual Antiplatelet therapy (DAPT) post stent insertion 🔻 DAPT example: Aspirin + clopidogrel/ticagrelo
🔺 Minimum duration of Dual Antiplatelet therapy (DAPT) post stent insertion 🔻 DAPT example: Aspirin + clopidogrel/ticagrelor

Repost from N/a
VHD, valvular heart disease
VHD, valvular heart disease

Antiplatelets indications in TIA
Antiplatelets indications in TIA

Repost from N/a
TIA transient ischemic attack management
TIA transient ischemic attack management

SIADH
SIADH

🔬 فرصة نشر بحث طبي ✅ التخصص: Internal Medicine/Toxicology نوفر لك فرصة مشاركة ونشر بحث طبي بالاضافة للحصول على الكورسات التالية: 📘 CREB – Comprehensive Review of Epidemiology & Biostatistics يغطي أساسيات البحث الطبي: اختيار الفكرة، جمع وتحليل البيانات، وكتابة البحث 👥 العمل ضمن فريق بحثي ⏳ المقاعد محدودة ⛔️ 🛒 التسجيل عبر سلة (Medicine With Alis) واتساب للاستفسارات 📱: +966581216150 🔗 رابط التسجيل: https://salla.sa/medicine-with-alis

syphilis treatment
syphilis treatment

Repost from N/a
🔰 Lung cancer: paraneoplastic syndromes
🔰 Lung cancer: paraneoplastic syndromes

Repost from N/a
Hemochromatosis
Hemochromatosis

Repost from N/a
🔰 Effects of Phlebotomy in Hereditary Hemochromatosis
🔰 Effects of Phlebotomy in Hereditary Hemochromatosis

Repost from N/a
🔰 Hypoglycemia: Investigations
🔰 Hypoglycemia: Investigations